Influence of wearing a safety shoe with a plantar foot sole-stimulating strap and a shoe last fitted to the natural shape of the foot on subjective pain and quality of life in workers with prolonged standing: a randomized-controlled trial

Influence of wearing a safety shoe with a plantar foot sole-stimulating strap and a shoe last fitted to the natural shape of the foot on subjective pain and quality of life in workers with prolonged standing: a randomized-controlled trial - Safety shoe and QoL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00026920

Enrollment

121

Registered

2021-10-18

Start date

2021-08-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Group 1: The intervention group wears the HAIX connexis safety shoe for four weeks Group 2: The control group wears the individually preferred own safety shoe

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: production worker Wolf GmbH

Exclusion criteria

Exclusion criteria: Participants were not allowed to be included in the intervention group if they wore a shoe size >50 or specially designed orthopaedic shoes, as for example one shoe with an elevated sole. Participants were also excluded if there was a diagnosis of the following: diabetes mellitus, sensibility disturbances in the area of the foot, complex regional pain syndrome or unspecific musculoskeletal disorders, like fibromyalgia.

Design outcomes

Primary

Measure	Time frame
Questionnaire baseline and follow-up (after 4 weeks of intervention) The questionnaire consists the following parts: - personal data - shoe evaluation (only for intervention group) - musculoskeletal problems - subjective swelling in the legs - foot health - quality of life - subjective feeling of exhaustion	—

Secondary

Measure	Time frame
No secondary outcomes were evaluated	—

Countries

Germany

Contacts

Public ContactAnna Gabriel

Technische Universität München

anna-gabriel@tum.de+ 49 (0) 89 289 24506

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026